CD274 and melanoma: The activation of the PD-L1 and PD-1 complex is related to immunosuppression, and promotes tumor progression in various tumors, including renal cell carcinoma, esophageal cancer, stomach cancer, melanoma, and HNSCC (17, 23–25).